GLP-1 Market
LLY $1164.89 ▲ +1.0% NVO $39.80 ▼ -8.0% PFE $27.74 ▲ +0.3% VKTX $30.11 ▲ +3.9% KLRA $11.99 ▼ -6.5% GPCR $36.81 ▲ +5.2% RHHBY $55.30 ▲ +2.1%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Valsartan

Company
University of Pennsylvania
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
32 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

32 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 22, 2026

Find a Clinical Trial Near Me

See recruiting studies for Valsartan and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02735707

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

    Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites
    Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
    View official trial listing →
  • Recruiting NCT NCT02817360

    NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

    Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites
    Type 2 diabetes Other conditions: Heart Diseases
    View official trial listing →
  • Recruiting NCT NCT02966665

    : Vascular Function in Health and Disease

    Not yet reported Russell Richardson 420 participants Est. completion 2026-08 1 site Stand-alone
    Heart failure Other conditions: Chronic Obstructive Pulmonary Disease, Pulmonary Artery Hypertension, Hypertension
    View official trial listing →
  • Recruiting NCT NCT03535376

    Bariatric Surgery and Pharmacokinetics of Valsartan

    Norwegian University of Science and Technology 12 participants Est. completion 2026-10 1 site
    Other conditions: Obesity, Morbid
    View official trial listing →
  • Recruiting NCT NCT04055428

    NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

    Not yet reported University of Alabama at Birmingham 200 participants Est. completion 2027-05-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Diabetes Mellitus, Insulin Sensitivity/Resistance, Metabolic Disease, Natriuretic Peptides, Metabolism, Energy Expenditure
    View official trial listing →
  • Recruiting NCT NCT04971720

    PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

    Not yet reported, Not yet reported University of Alabama at Birmingham 160 participants Est. completion 2027-01-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Obesity, Hypertension, Nocturnal Blood Pressure, Natriuretic Peptides, Renin-Angiotensin-Aldosterone System
    View official trial listing →
  • Recruiting NCT NCT05155137

    Polypill and RiscOMeter to Prevent StrOke and CogniTive ImpairmEnt (PROMOTE)

    Not yet reported Hospital Moinhos de Vento 8518 participants Est. completion 2030-12-14 2 sites Stand-alone
    Cardiovascular disease Other conditions: Cognitive Decline
    View official trial listing →
  • Recruiting NCT NCT05194111

    Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/Valsartan

    Not yet reported, Not yet reported Virginia Commonwealth University 70 participants Est. completion 2028-11-30 1 site Stand-alone
    Heart failure Other conditions: Heart Dysfunction
    View official trial listing →
  • Recruiting NCT NCT05465031

    Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

    Not yet reported Silesian Centre for Heart Diseases 600 participants Est. completion 2029-02 4 sites Stand-alone
    Heart failure Other conditions: Breast Cancer, Neoplasm, Breast, Breast Diseases, Antihypertensive Agents, Sacubitril/Valsartan, Angiotensin II Type 1 Receptor Blockers, Angiotensin Receptor Antagonists, Molecular Mechanisms of Pharmacological Action, Cardiac Toxicity, Cancer, Therapy-Related, Cancer Therapy-Related Cardiac Dysfunction, Cardiotoxicity
    View official trial listing →
  • Recruiting NCT NCT05498675

    Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

    Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
    Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
    View official trial listing →
  • Recruiting NCT NCT05508035

    The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction

    Not yet reported John Paul II Hospital, Krakow 488 participants Est. completion 2028-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT05764057

    DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction

    Not yet reported Assistance Publique - Hôpitaux de Paris 450 participants Est. completion 2026-10-12 1 site Stand-alone
    Other conditions: AMI, STEMI, NSTEMI, Left Ventricular Dysfunction
    View official trial listing →
  • Recruiting NCT NCT06053580

    Repurposing Valsartan May Protect Against Pulmonary Hypertension

    Not yet reported University of Washington 60 participants Est. completion 2027-07-01 1 site Stand-alone
    Heart failure Other conditions: Pulmonary Arterial Hypertension, Right Ventricular Dysfunction, Pulmonary Vascular Disorder
    View official trial listing →
  • Recruiting NCT NCT06218199

    Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts

    Not yet reported Heart Center Research, LLC 80 participants Est. completion 2026-12-31 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06283420

    Metabolic Response to the Initiation of Heart Failure Therapy

    Vojtech Melenovsky, MD, PhD 120 participants Est. completion 2026-12-20 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06625346

    Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.

    The Searle Company Limited Pakistan 420 participants Est. completion 2025-09-15 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Recruiting NCT NCT06643819

    Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A

    Not yet reported Chong Kun Dang Pharmaceutical 324 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Recruiting NCT NCT06659393

    Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure)

    Novartis Pharmaceuticals 30 participants Est. completion 2027-11-30 28 sites
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06693674

    Effect of Sacubitril-Valsartan on Cardiac Structure and Function

    Not yet reported Mayo Clinic 45 participants Est. completion 2026-12 1 site
    Other conditions: Congenital Heart Disease
    View official trial listing →
  • Recruiting NCT NCT06704633

    Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania

    Not yet reported Martin Rohacek 298 participants Est. completion 2028-11-30 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06930885

    Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

    Not yet reported Hospital do Coracao 7713 participants Est. completion 2031-05 13 sites Stand-alone
    Cardiovascular disease Other conditions: Atherothrombotic Diseases
    View official trial listing →
  • Recruiting NCT NCT07192341

    Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction

    Not yet reported Kafrelsheikh University 220 participants Est. completion 2026-02-01 1 site Stand-alone
    Heart failure Other conditions: Sacubitril/Valsartan, Prosthetic Heart Valve, Reduced Ejection Fraction
    View official trial listing →
  • Recruiting NCT NCT07331389

    A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

    Not yet reported Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 111 participants Est. completion 2026-06-13 1 site Stand-alone
    Other conditions: Overweight Subject, Healthy Subjects
    View official trial listing →
  • Recruiting NCT NCT07335900

    A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis

    Not yet reported RenJi Hospital 25 participants Est. completion 2027-05-30 1 site Stand-alone
    Other conditions: Severe Aortic Valve Stenosis
    View official trial listing →
  • Recruiting NCT NCT07347925

    Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF

    Future University in Egypt 140 participants Est. completion 2026-05-01 1 site
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07444398

    Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial

    Not yet reported Khawaja Danish Ali 130 participants Est. completion 2026-03-31 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07458880

    Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control

    Not yet reported The University of Hong Kong 140 participants Est. completion 2030-06-30 4 sites
    Other conditions: Intracerebral Hemorrhage
    View official trial listing →
  • Recruiting NCT NCT07465653

    A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction

    Not yet reported Novartis Pharmaceuticals 12 participants Est. completion 2026-09-24 6 sites
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07491718

    Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Cardiomyopathy

    Not yet reported University of Edinburgh 100 participants Est. completion 2028-08-09 1 site
    Other conditions: Takotsubo Cardiomyopathy
    View official trial listing →
  • Recruiting NCT NCT07513883

    The Assessment of Partial Guideline-Directed Medical Therapy Down Titration in Heart Failure in Remission.

    Not yet reported Ziekenhuis Oost-Limburg 100 participants Est. completion 2028-12 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT07572032

    Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study

    Not yet reported Kyungsub Song 80 participants Est. completion 2028-12-20 4 sites Stand-alone
    Cardiovascular diseaseHeart failure Other conditions: Valvular Cardiomyopathy
    View official trial listing →
  • Recruiting NCT NCT07631156

    STEPwise De-escalation and Optimizing Withdrawal of ARNI and SGLT2i in Normalized Heart Failure

    Not yet reported Kyungsub Song 80 participants Est. completion 2029-12-30 5 sites Stand-alone
    Heart failure Other conditions: Ventricular Dysfunction, Left
    View official trial listing →
  • Completed NCT NCT00034840

    Telmisartan vs. Valsartan in Patients With Mild to Moderate Hypertension Following a Missed Dose

    Not yet reported Boehringer Ingelheim 490 participants Est. completion 2002-08 35 sites
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00089518

    Optimal Treatment for Kidney Disease in HIV Infected Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 sites
    Other conditions: HIV Infections, Kidney Disease
    View official trial listing →
  • Completed NCT NCT00097786

    Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications

    Not yet reported Novartis Pharmaceuticals 9306 participants Est. completion 2009-10 38 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00129233

    Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose Intolerance

    Not yet reported Nagoya University 1150 participants Est. completion 2013-04 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00130156

    Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

    Not yet reported Eisai Inc. 93 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: High Blood Pressure
    View official trial listing →
  • Terminated NCT NCT00140790

    Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study

    Not yet reported Kumamoto University 1000 participants Est. completion 2015-03 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00149227

    Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)

    Not yet reported Kyoto Prefectural University of Medicine 3031 participants Est. completion 2009-01 1 site Stand-alone
    Heart failureCardiovascular disease Other conditions: Hypertension, Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00151229

    Valsartan in Elderly Isolated Systolic Hypertension Study

    Not yet reported VALISH study 3079 participants Est. completion 2008-03 1 site
    Other conditions: Aged, Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT00153023

    1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy

    Not yet reported Boehringer Ingelheim 885 participants Est. completion 2005-12 111 sites
    Other conditions: Diabetic Nephropathies, Hypertension
    View official trial listing →
  • Completed NCT NCT00154271

    Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)

    Not yet reported Novartis 1677 participants Est. completion 2005-06
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00168779

    Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

    Not yet reported Boehringer Ingelheim 1185 participants Est. completion 2006-07 113 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00170937

    A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome

    Not yet reported Novartis 507 participants 1 site
    Metabolic syndrome Other conditions: HYPERTENSION, PRE-HYPERTENSION
    View official trial listing →
  • Completed NCT NCT00170963

    Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

    Not yet reported Novartis 1018 participants Est. completion 2005-06 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00170976

    A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

    Not yet reported Novartis 403 participants Est. completion 2005-06 2 sites
    Other conditions: HYPERTENSION
    View official trial listing →
  • Completed NCT NCT00170989

    Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

    Not yet reported Novartis 2714 participants Est. completion 2005-07 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171002

    Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

    Not yet reported Novartis 936 participants Est. completion 2005-06 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171015

    VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil

    Not yet reported Novartis 212 participants Est. completion 2005-04 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171028

    A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension

    Not yet reported Novartis 90 participants Est. completion 2006-11 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171054

    Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension

    Not yet reported Novartis 125 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171106

    Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure

    Not yet reported Novartis 150 participants Est. completion 2008-02 2 sites
    Heart failure
    View official trial listing →
  • Terminated NCT NCT00171119

    A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

    Not yet reported Novartis Pharmaceuticals 81 participants 1 site
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171327

    Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction

    Not yet reported Novartis 213 participants Est. completion 2005-09 1 site
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00171353

    A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure

    Not yet reported Novartis 109 participants Est. completion 2005-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171444

    Comparison of Two Treatment Strategies in Hypertensive Patients

    Not yet reported Novartis 4445 participants Est. completion 2005-05
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171535

    Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

    Not yet reported Novartis 130 participants Est. completion 2005-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171561

    Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.

    Not yet reported Novartis 144 participants Est. completion 2006-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171574

    Antiproteinuric Effect of Valsartan and Lisinopril

    Not yet reported Novartis 124 participants Est. completion 2006-07 1 site
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00171600

    Antialbuminuric Effects of Valsartan and Lisinopril

    Not yet reported Novartis 54 participants Est. completion 2007-01 1 site
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171756

    Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.

    Not yet reported Novartis 92 participants Est. completion 2006-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00171782

    Hypertension and Cardiovascular Risk Factors

    Not yet reported Novartis 76 participants Est. completion 2004-12
    Other conditions: HYPERTENSION
    View official trial listing →
  • Completed NCT NCT00185055

    The Relative Effects of Olmesartan Medoxomil, Irbesartan and Valsartan on the Activity of the Blood Pressure Control System in Healthy Subjects

    Not yet reported Daiichi Sankyo 20 participants Est. completion 2005-02
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00190580

    Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease

    Not yet reported KVT-Study Group 312 participants Est. completion 2008-04 1 site Stand-alone
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00202618

    Rationale and Design for Shiga Microalbuminuria Reduction Trial

    Not yet reported Shiga University 160 participants Est. completion 2006-06 1 site
    Other conditions: Hypertension, Diabetes Mellitus, Albuminuria
    View official trial listing →
  • Completed NCT NCT00208767

    Effect of Valsartan on Carotid Artery Disease

    Not yet reported Emory University 120 participants Est. completion 2009-11 1 site
    Other conditions: Carotid Artery Diseases, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00219102

    A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients

    Not yet reported Novartis 336 participants Est. completion 2007-05 7 sites
    Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Completed NCT NCT00219180

    Clinical Study to Evaluate Efficacy and Safety of Aliskiren (150mg & 300mg) Administered Alone and in Combo With Valsartan (160mg and 320mg) in Patients With High Blood Pressure

    Not yet reported Novartis 1797 participants Est. completion 2006-09 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00219193

    A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders Patients

    Not yet reported Novartis 641 participants Est. completion 2007-01 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00239538

    SMOOTH - Blood Pressure Control in Diabetic/Obese Patients

    Not yet reported Boehringer Ingelheim 840 participants Est. completion 2004-12 102 sites
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00240448

    A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients

    Not yet reported Boehringer Ingelheim 1109 participants 100 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00241007

    A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension

    Not yet reported Novartis 836 participants Est. completion 2005-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00241072

    Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance

    Not yet reported Novartis 27 participants Est. completion 2005-07
    Prediabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00241098

    The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure

    Not yet reported Novartis 37 participants Est. completion 2005-06
    Heart failure Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00241124

    Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes

    Not yet reported Novartis 1099 participants Est. completion 2005-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00241150

    Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic Syndrome

    Not yet reported Novartis 80 participants Est. completion 2005-01
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00250562

    A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

    Not yet reported Novartis 1171 participants Est. completion 2006-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00254475

    A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia

    Not yet reported Novartis 871 participants Est. completion 2006-09 2 sites
    Other conditions: Essential Hypertension, Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT00273299

    Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension

    Not yet reported Novartis 607 participants Est. completion 2006-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00277472

    Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension

    Not yet reported Novartis 300 participants 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00295542

    Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

    Not yet reported University of Vigo 3344 participants Est. completion 2009-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00302705

    Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose

    Not yet reported University of Vigo 150 participants Est. completion 2007-03 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00308425

    Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS

    Not yet reported Novartis 119 participants Est. completion 2005-06
    Other conditions: De Novo Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00310778

    Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-Blocker

    Not yet reported Assistance Publique - Hôpitaux de Paris 64 participants Est. completion 2007-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00311740

    A Study of VAH631 in Patients With Essential Hypertension (Factorial Study)

    Not yet reported Novartis 582 participants Est. completion 2006-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00327145

    A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy

    Not yet reported Novartis 894 participants Est. completion 2007-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00327587

    8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension

    Not yet reported Novartis 2279 participants Est. completion 2007-08 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00333489

    Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in Hypertension

    Not yet reported Novartis 551 participants Est. completion 2005-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00338936

    Long Term Study of VAH631 in Patients With Essential Hypertension (Extension From B1303 Study)

    Not yet reported Novartis 362 participants Est. completion 2007-09
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00343499

    The Use of DIOVAN to Reduce Post-Cardioversion Recurrence of Atrial Fibrillation Trial (the DRAFT Trial)

    Not yet reported Intermountain Health Care, Inc. 200 participants Est. completion 2007-07 3 sites
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00350168

    Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

    Not yet reported Novartis 647 participants Est. completion 2007-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00351130

    Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

    Not yet reported Novartis 79 participants Est. completion 2007-03 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00353912

    Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

    Not yet reported Novartis 571 participants Est. completion 2007-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00360178

    Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide

    Not yet reported Novartis 198 participants Est. completion 2006-12 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00367562

    Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy

    Not yet reported Hospital Britanico 20 participants Est. completion 2005-12 1 site
    Other conditions: IGA Nephropathy
    View official trial listing →
  • Completed NCT NCT00367939

    Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine

    Not yet reported Novartis 132 participants Est. completion 2006-07 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00376272

    GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence

    Not yet reported Gruppo di Ricerca GISSI 1442 participants Est. completion 2008-03 114 sites Stand-alone
    Other conditions: Atrial Fibrillation
    View official trial listing →
  • Completed NCT NCT00385931

    Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin

    Not yet reported Novartis 412 participants Est. completion 2003-04 1 site
    Other conditions: Hypertension, Hypercholesterolemia, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT00386607

    A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.

    Not yet reported Novartis 601 participants Est. completion 2008-07 4 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00391846

    Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone

    Not yet reported AstraZeneca 252 participants Est. completion 2009-01 39 sites
    Heart failure Other conditions: Ventricular Dysfunction, Left
    View official trial listing →
  • Completed NCT NCT00392262

    A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients

    Not yet reported Novartis 224 participants Est. completion 2007-02 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00394745

    Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

    Not yet reported Novartis 45 participants Est. completion 2007-06 2 sites
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00394823

    VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients

    Not yet reported Novartis 206 participants Est. completion 2007-06 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00396656

    Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients

    Not yet reported Novartis 30 participants Est. completion 2007-12 2 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00400777

    Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension

    Not yet reported Novartis 460 participants Est. completion 2008-06 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00407680

    Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With Hypertension

    Not yet reported Kitasato University 80 participants Est. completion 2009-03 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00409487

    Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients

    Not yet reported University Hospital, Grenoble 60 participants Est. completion 2009-05 1 site
    Obstructive sleep apnea Other conditions: Hypertension,
    View official trial listing →
  • Completed NCT NCT00409578

    Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome

    Not yet reported Novartis 1101 participants Est. completion 2009-04 11 sites Stand-alone
    Other conditions: Post Acute Coronary Syndrome, Myocardial Ischemia
    View official trial listing →
  • Completed NCT NCT00409643

    Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients

    Not yet reported Novartis 1259 participants Est. completion 2004-07 2 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00409760

    Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.

    Not yet reported Novartis 1930 participants Est. completion 2004-02 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00413049

    Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

    Not yet reported Novartis 698 participants Est. completion 2007-11 12 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00413413

    Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension

    Not yet reported Novartis Pharmaceuticals 1134 participants Est. completion 2007-11 19 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00415883

    To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers

    Not yet reported Novartis 40 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00416468

    Bioavailability of Aliskiren and Valsartan Combined as a Single Tablet vs. the Same Medications Given Separately to Healthy Subjects.

    Not yet reported Novartis 32 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00416728

    Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.

    Not yet reported Novartis 32 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00424801

    Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris

    Not yet reported University of Aarhus 10 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Microvascular Angina, Hypertension
    View official trial listing →
  • Completed NCT NCT00425373

    Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

    Not yet reported, Not yet reported Novartis Pharmaceuticals 1474 participants Est. completion 2008-03 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00425997

    Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension

    Not yet reported Novartis 480 participants Est. completion 2007-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00426348

    A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy

    Not yet reported Guangdong Provincial People's Hospital 75 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Glomerulonephritis, IGA Nephropathy
    View official trial listing →
  • Completed NCT NCT00426478

    Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients

    Not yet reported Novartis 80 participants Est. completion 2007-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00433836

    Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure

    Not yet reported Novartis Pharmaceuticals 300 participants Est. completion 2009-02 11 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00435162

    Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure

    Not yet reported Novartis Pharmaceuticals 74 participants Est. completion 2009-01 11 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00437645

    Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 1183 participants Est. completion 2007-11 12 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00439738

    Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults

    Not yet reported Novartis Pharmaceuticals 412 participants 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00446511

    Extension Study to Assess Long Term Safety, Tolerability, and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension

    Not yet reported Novartis Pharmaceuticals 250 participants Est. completion 2009-06 9 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00446563

    Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy

    Not yet reported Novartis 90 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Hypertension; Hypertrophy, Left Ventricular
    View official trial listing →
  • Completed NCT NCT00457483

    Nijmegen Antihypertensive Management Improvement Study

    Not yet reported Radboud University Medical Center 120 participants Est. completion 2011-03 1 site
    Other conditions: Primary Hypertension
    View official trial listing →
  • Completed NCT NCT00457626

    A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

    Not yet reported Novartis Pharmaceuticals 66 participants Est. completion 2009-05-25 36 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00460213

    Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study

    Not yet reported Kitakyushu-Tsuyazaki Hospital 103 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00487123

    Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

    Not yet reported Novartis Est. completion 2007-09 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00500604

    Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension

    Not yet reported Sanofi 1617 participants Est. completion 2010-01 14 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00503152

    Preventing Microalbuminuria in Type 2 Diabetes

    Not yet reported Mario Negri Institute for Pharmacological Research 612 participants Est. completion 2016-09 9 sites Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00518219

    To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)

    Not yet reported Nanjing University School of Medicine 68 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT00518362

    To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)

    Not yet reported Nanjing University School of Medicine 67 participants Est. completion 2010-03 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT00518479

    Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression

    Not yet reported University of Leeds 42 participants Est. completion 2004-04 1 site Stand-alone
    Other conditions: Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT00523549

    The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction

    Not yet reported Novartis Pharmaceuticals 229 participants Est. completion 2008-01 1 site Stand-alone
    Other conditions: Hypertension, Diastolic Dysfunction
    View official trial listing →
  • Completed NCT NCT00530595

    Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

    Not yet reported Saitama Medical University
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00546754

    BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)

    Not yet reported Organon and Co 808 participants Est. completion 2009-05-01
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00548067

    Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension

    Not yet reported Novartis 111 participants Est. completion 2008-03 5 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00549770

    Efficacy and Safety of LCZ696A in Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 1334 participants Est. completion 2008-07 182 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00550095

    To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus

    Not yet reported Novartis 509 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Microalbuminuria, Proteinuria
    View official trial listing →
  • Completed NCT NCT00589732

    Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent

    Not yet reported Seung-Jung Park 220 participants Est. completion 2009-12 5 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00591578

    Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension

    Not yet reported Takeda 984 participants Est. completion 2010-03 88 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00599885

    Comparison of Effects of Telmisartan and Valsartan on Neointima Volume in Diabetes

    Not yet reported Korea University Anam Hospital 72 participants 1 site
    Cardiovascular disease Other conditions: Hypertension, Diabetes
    View official trial listing →
  • Status unknown NCT NCT00655330

    Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

    Not yet reported Guangdong Provincial People's Hospital 170 participants Est. completion 2017-05 1 site Stand-alone
    Type 2 diabetes Other conditions: Nephropathy
    View official trial listing →
  • Completed NCT NCT00657241

    Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

    Not yet reported State University of New York at Buffalo 30 participants Est. completion 2010-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00664846

    Standard Medical Management in Secondary Prevention of Ischemic Stroke in China

    Not yet reported Peking Union Medical College Hospital 4000 participants Est. completion 2011-04 46 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00666536

    The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy

    Not yet reported Novartis 728 participants 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00684489

    Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

    Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00687973

    Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg

    Not yet reported Novartis Pharmaceuticals 393 participants Est. completion 2009-01 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00691314

    Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis

    Not yet reported Peking Union Medical College Hospital 300 participants Est. completion 2010-12 10 sites Stand-alone
    Cardiovascular disease Other conditions: Transient Ischemic Attack, Atherosclerosis, Stenosis, Stents
    View official trial listing →
  • Completed NCT NCT00698646

    Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.

    Not yet reported Novartis Pharmaceuticals 384 participants Est. completion 2009-06 20 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00699192

    Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 965 participants Est. completion 2009-05 18 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00700271

    Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a Day

    Not yet reported Novartis Pharmaceuticals 478 participants Est. completion 2008-08 2 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT00716950

    Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients

    Not yet reported University of Pavia 187 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00721773

    Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients

    Not yet reported Sun Yat-sen University 200 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Renal Function Disorder
    View official trial listing →
  • Status unknown NCT NCT00732966

    Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?

    Not yet reported Assaf-Harofeh Medical Center 30 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT00738972

    Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)

    Not yet reported Fundación Lindavista del Corazón AC 12 participants Est. completion 2010-08 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00741585

    Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

    Not yet reported University of Vigo 21983 participants Est. completion 2018-06-30 20 sites
    Cardiovascular diseaseChronic kidney disease Other conditions: Essential Hypertension
    View official trial listing →
  • Withdrawn NCT NCT00745953

    Regression of Fatty Heart by Valsartan Therapy

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2009-08 1 site
    Metabolic syndrome Other conditions: Lipotoxicity
    View official trial listing →
  • Status unknown NCT NCT00790946

    Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study)

    Not yet reported Kagoshima University 250 participants Est. completion 2009-12 1 site
    Other conditions: Hypertension, Obesity
    View official trial listing →
  • Completed NCT NCT00809926

    8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension

    Not yet reported Novartis 451 participants Est. completion 2009-07 1 site Stand-alone
    Other conditions: Stage 2 Hypertension
    View official trial listing →
  • Completed NCT NCT00819767

    Efficacy and Safety of Aliskiren in Patients With Mild to Moderate Hypertension During Exercise

    Not yet reported Novartis 68 participants Est. completion 2009-10 8 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00821574

    Reducing the Overall Risk Level in Patients Suffering From Metabolic Syndrome

    Not yet reported Novartis 144 participants Est. completion 2007-03 Stand-alone
    Other conditions: Hypertension, Dyslypidaemia
    View official trial listing →
  • Completed NCT NCT00839683

    Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects

    Not yet reported AstraZeneca 24 participants Est. completion 2009-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT00858299

    The Change of Urinary Angiotensinogen Excretion After Valsartan Treatment in Patients With Persistent Proteinuria

    Not yet reported Samsung Medical Center 500 participants Est. completion 2011-12 1 site Stand-alone
    Chronic kidney disease Other conditions: Proteinuria
    View official trial listing →
  • Status unknown NCT NCT00874601

    Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke

    Not yet reported Hallym University Medical Center 578 participants Est. completion 2012-07 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00878969

    Genes, Fibrinolysis and Endothelial Dysfunction- Dialysis Aim 3

    Not yet reported Vanderbilt University 78 participants Est. completion 2015-06 1 site
    Other conditions: Oxidative Stress, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT00913653

    Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure

    Not yet reported Novartis Pharmaceuticals 30 participants 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT00921570

    The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension

    Not yet reported Gulhane School of Medicine 105 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Diabetes, Hypertension, Proteinuria
    View official trial listing →
  • Completed NCT NCT00922441

    A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

    Not yet reported Boryung Pharmaceutical Co., Ltd 92 participants Est. completion 2009-08
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT00927394

    Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus

    Not yet reported Novartis 1143 participants Est. completion 2011-10 4 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00939588

    Compare the Effect of Aliskiren Plus Valsartan Versus Angiotensin-Converting Enzyme Inhibitor (ACEi) Plus Angiotensin Receptor Blocker (ARB) [Ramipril Plus Telmisartan] on the Renin-Angiotensin-Aldosterone System (RAAS) in Hypertensive Patients

    Not yet reported Novartis Pharmaceuticals 88 participants 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00982358

    Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus

    Not yet reported Charite University, Berlin, Germany 121 participants Est. completion 2007-03 2 sites
    Type 2 diabetesCardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00993109

    Low-dose Nifedipine-Valsartan Combination Compared to Up-titrated Valsartan Monotherapy in Essential Hypertension

    Not yet reported Bayer 360 participants Est. completion 2011-05 17 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01001572

    Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

    Not yet reported Novartis 932 participants Est. completion 2010-05 2 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01030458

    Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) Trial

    Not yet reported KU Leuven 183 participants Est. completion 2012-03 7 sites Stand-alone
    Other conditions: Blood Pressure
    View official trial listing →
  • Terminated NCT NCT01035255

    This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure

    Not yet reported Novartis Pharmaceuticals 8442 participants Est. completion 2014-05 1031 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT01070043

    To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone

    Not yet reported Novartis 60 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Hypertension, High Blood Pressure
    View official trial listing →
  • Completed NCT NCT01071122

    FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

    Not yet reported Bayer 365 participants Est. completion 2012-02 15 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01095822

    Effects of Valsartan and Aliskiren on Hemostatic Indices in Hypertensive Diabetics

    Not yet reported HeartDrug Research LLC 50 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01122251

    Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension

    Not yet reported LG Life Sciences 441 participants Est. completion 2010-07 2 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Terminated NCT NCT01129557

    Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease

    Not yet reported Columbia University 46 participants Est. completion 2012-12 1 site
    Chronic kidney disease Other conditions: Proteinuric Kidney Disease, Hypertensive Nephrosclerosis, IgA Nephropathy, Focal Segmental Glomerulosclerosis, Glomerulopathy (Obesity-associated), Glomerulonephritis, Membranous
    View official trial listing →
  • Completed NCT NCT01167153

    Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

    Not yet reported Novartis 564 participants Est. completion 2011-04 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01193101

    Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 389 participants Est. completion 2011-04 34 sites
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01198496

    Recurrent Stroke Prevention Clinical Outcome Study

    Not yet reported Biomedis International Ltd. 5000 participants Est. completion 2019-12 1 site
    Cardiovascular disease Other conditions: Hypertension, Blood Pressure
    View official trial listing →
  • Completed NCT NCT01232049

    Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101)

    Not yet reported Asan Medical Center 24 participants 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01241487

    A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

    Not yet reported Novartis 150 participants Est. completion 2011-01 1 site Stand-alone
    Other conditions: Primary Hypertension
    View official trial listing →
  • Terminated NCT NCT01252238

    Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic Compliance

    Not yet reported Brigham and Women's Hospital 24 participants Est. completion 2012-12 1 site
    Other conditions: Insulin Sensitivity, Aortic Compliance, Diastolic Function
    View official trial listing →
  • Completed NCT NCT01271985

    Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill

    Not yet reported Tehran University of Medical Sciences 8410 participants Est. completion 2019-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01281306

    An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension

    Not yet reported Novartis Pharmaceuticals 910 participants Est. completion 2011-12 90 sites Stand-alone
    Other conditions: Systolic Hypertension
    View official trial listing →
  • Completed NCT NCT01318395

    Aliskiren on Retinal Vasculature Treatment Study

    Not yet reported University of Erlangen-Nürnberg Medical School 56 participants Est. completion 2013-06 2 sites
    Other conditions: Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT01340326

    The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling

    Not yet reported Dong-A University 800 participants Est. completion 2014-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01353508

    Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers

    Not yet reported Novartis Pharmaceuticals 32 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01365481

    Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

    Not yet reported Novartis Pharmaceuticals 150 participants Est. completion 2015-09 28 sites Stand-alone
    Chronic kidney disease Other conditions: Hypertension
    View official trial listing →
  • Terminated NCT NCT01368536

    Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes

    Not yet reported Novartis Pharmaceuticals 975 participants Est. completion 2012-02 97 sites Stand-alone
    Other conditions: Hypertension, Stage 2 Hypertension, Diabetes
    View official trial listing →
  • Completed NCT NCT01375322

    ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

    Not yet reported TSH Biopharm Corporation Limited 226 participants Est. completion 2010-06 4 sites
    Type 2 diabetes Other conditions: Hypertension, Albuminuria
    View official trial listing →
  • Status unknown NCT NCT01377285

    Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)

    Not yet reported National Taiwan University Hospital 350 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Chronic Renal Failure
    View official trial listing →
  • Withdrawn NCT NCT01400256

    Blood Pressure Lowering in Acute Stroke Trial

    Not yet reported Stanford University Est. completion 2009-02 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01402843

    Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia

    Not yet reported JW Pharmaceutical 150 participants Est. completion 2013-01 10 sites Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT01406431

    Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

    Not yet reported JW Pharmaceutical 48 participants Est. completion 2012-10 1 site
    Other conditions: Hyperlipidemia, Hypertension
    View official trial listing →
  • Completed NCT NCT01415505

    Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension

    Not yet reported Forest Laboratories 812 participants Est. completion 2013-04 135 sites
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01432106

    The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome

    Not yet reported University of Michigan Est. completion 2012-12 1 site
    Metabolic syndrome Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01447485

    Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients

    Not yet reported Novartis Pharmaceuticals 12 participants Est. completion 2011-10 2 sites Stand-alone
    Chronic kidney disease Other conditions: Hypertension, Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT01494727

    Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mg

    Not yet reported HK inno.N Corporation 48 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01508026

    Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

    Not yet reported Forest Laboratories 4161 participants Est. completion 2013-05 413 sites Stand-alone
    Other conditions: Stage 1 Hypertension, Stage 2 Hypertension
    View official trial listing →
  • Completed NCT NCT01518855

    Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential Hypertension

    Not yet reported Bayer 514 participants Est. completion 2005-04 4 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01541189

    Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

    Not yet reported Novartis Pharmaceuticals 200 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01569815

    Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

    Not yet reported Novartis Pharmaceuticals 32 participants Est. completion 2014-08 3 sites
    Other conditions: Mild and Moderate Renal Impairment
    View official trial listing →
  • Completed NCT NCT01569828

    Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function

    Not yet reported Novartis Pharmaceuticals 12 participants Est. completion 2009-09 3 sites
    Other conditions: Pharmacokinetics, Renal Impaired, Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT01599104

    Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 1161 participants Est. completion 2013-04 61 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01601470

    Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension

    Not yet reported Novartis Pharmaceuticals 28 participants Est. completion 2013-01 1 site
    Other conditions: Mild to Moderate Hypertension
    View official trial listing →
  • Completed NCT NCT01609907

    Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

    Not yet reported Yuhan Corporation 30 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01609959

    New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering

    Not yet reported Nara Medical University 70 participants Est. completion 2013-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01615198

    Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 588 participants Est. completion 2013-07 79 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01617681

    Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

    Not yet reported Novartis Pharmaceuticals 127 participants Est. completion 2017-01-24 27 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT01621633

    A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers

    Not yet reported Novartis Pharmaceuticals 32 participants Est. completion 2013-01 1 site
    Other conditions: Hepatic Impairment
    View official trial listing →
  • Completed NCT NCT01646671

    Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients

    Not yet reported Novartis Pharmaceuticals 35 participants Est. completion 2013-02 9 sites
    Other conditions: Severe Hypertension
    View official trial listing →
  • Completed NCT NCT01652339

    Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects

    Not yet reported Hanlim Pharm. Co., Ltd. 40 participants Est. completion 2012-12 1 site Stand-alone
    Other conditions: Healthy Male Subjects
    View official trial listing →
  • Completed NCT NCT01663233

    Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine

    Not yet reported Novartis Pharmaceuticals 266 participants Est. completion 2013-05 28 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01672476

    A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension

    Not yet reported Boryung Pharmaceutical Co., Ltd 293 participants Est. completion 2013-04 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01681576

    Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension

    Not yet reported Novartis Pharmaceuticals 72 participants Est. completion 2013-10 15 sites Stand-alone
    Other conditions: Salt-sensitive Hypertension
    View official trial listing →
  • Completed NCT NCT01692301

    Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension

    Not yet reported Novartis Pharmaceuticals 454 participants Est. completion 2015-04 47 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01699490

    Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder

    Not yet reported National Cheng-Kung University Hospital 200 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Status unknown NCT NCT01715584

    Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01735890

    Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg Tablet

    Not yet reported HK inno.N Corporation 48 participants Est. completion 2012-11 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01764178

    To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

    Not yet reported JW Pharmaceutical 52 participants Est. completion 2013-12-27 1 site Stand-alone
    Other conditions: Hyperlipidemia, Hypertension
    View official trial listing →
  • Completed NCT NCT01767259

    Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide

    Not yet reported Damanhour University 24 participants Est. completion 2012-12 1 site
    Other conditions: Healthy Normotensive Participants
    View official trial listing →
  • Completed NCT NCT01767298

    Pharmacokinetic Interactions of Valsartan and Hydrochlorothiazide (Double Doses)

    Not yet reported Damanhour University 24 participants Est. completion 2012-12
    Other conditions: Healthy Normotensive Participants
    View official trial listing →
  • Completed NCT NCT01776047

    A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

    Not yet reported Dong-A Pharmaceutical Co., Ltd. 51 participants Est. completion 2012-09
    Other conditions: Healthy Male Volunteer
    View official trial listing →
  • Completed NCT NCT01785472

    Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension

    Not yet reported Novartis Pharmaceuticals 1438 participants Est. completion 2014-08 50 sites
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01819220

    Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

    Not yet reported Yonsei University 16 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01819779

    Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)

    Not yet reported Hanlim Pharm. Co., Ltd. 53 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Healthy Male Subjects
    View official trial listing →
  • Completed NCT NCT01838967

    A Drug Interaction Study of Cilnidipine and Valsartan

    Not yet reported IlDong Pharmaceutical Co Ltd 54 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01850160

    Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension

    Not yet reported Farma de Colombia SA 124 participants Est. completion 2015-05 8 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT01865188

    Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension

    Not yet reported Novartis Pharmaceuticals Est. completion 2015-04
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01870739

    A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

    Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2015-06 4 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01878201

    A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

    Not yet reported Boryung Pharmaceutical Co., Ltd 75 participants Est. completion 2014-02 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT01904981

    Comparison of Beta-blocker Versus Angiotensin Receptor Blocker for Suppression of Aneurysm Expansion in Patients With Small Abdominal Aortic Aneurysm and Hypertension (BASE Trial)

    Not yet reported Yonsei University 19 participants Est. completion 2017-04-18 1 site Stand-alone
    Other conditions: Small Abdominal Aortic Aneurysm
    View official trial listing →
  • Completed NCT NCT01912534

    Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM

    Not yet reported Carelon Research 211 participants Est. completion 2019-07 15 sites
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01917149

    Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy

    Not yet reported Xijing Hospital 480 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Dilated Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT01918332

    Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia

    Not yet reported LG Life Sciences 168 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Hypertension,, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01918358

    Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg

    Not yet reported LG Life Sciences 60 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01918709

    Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers

    Not yet reported LG Life Sciences 30 participants Est. completion 2011-11 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT01922089

    Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

    Not yet reported Novartis Pharmaceuticals 498 participants Est. completion 2014-08 105 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT01928628

    Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients

    Not yet reported LG Life Sciences 449 participants 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT01992796

    Angiotensin II Antagonist in Severe Sepsis

    Not yet reported University of Salerno 300 participants Est. completion 2017-01 1 site
    Other conditions: Severe Sepsis
    View official trial listing →
  • Completed NCT NCT02058446

    PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

    Not yet reported TSH Biopharm Corporation Limited 36 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02062645

    Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

    Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2015-09 8 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02069821

    Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male Subjects

    Not yet reported HK inno.N Corporation 56 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02088008

    A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination Tablet With Coadministration of Cilnidipine and Valsartan

    Not yet reported IlDong Pharmaceutical Co Ltd 54 participants 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02130687

    Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

    Not yet reported Vanderbilt University 106 participants Est. completion 2020-08 1 site
    Type 2 diabetes Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02145104

    Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension

    Not yet reported IlDong Pharmaceutical Co Ltd 286 participants Est. completion 2016-09-29 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02177396

    MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring

    Not yet reported Boehringer Ingelheim 426 participants
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02197442

    Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions

    Not yet reported Ranbaxy Laboratories Limited 36 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02197494

    Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

    Not yet reported Ranbaxy Laboratories Limited 40 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02200822

    Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients

    Not yet reported Hasselt University 80 participants Est. completion 2019-02 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT02226120

    Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction

    Not yet reported Novartis Pharmaceuticals 1980 participants Est. completion 2017-12-28 394 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT02242318

    Study to Evaluate Efficacy of Micardis® (Telmisartan) and Valsartan in Patients With Mild-to-moderate Hypertension After Missing One Dose Using Ambulatory Blood Pressure Monitoring

    Not yet reported Boehringer Ingelheim 440 participants
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT02299310

    Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease

    Not yet reported Chinese PLA General Hospital 60 participants Est. completion 2015-12 1 site Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02343250

    A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan

    Not yet reported IlDong Pharmaceutical Co Ltd 54 participants Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • No Longer Available NCT NCT02389933

    Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)

    Novartis Pharmaceuticals 286 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02403349

    Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol

    Not yet reported Ajou University School of Medicine 105 participants Est. completion 2015-09
    Cardiovascular disease Other conditions: Blood Pressure
    View official trial listing →
  • Status unknown NCT NCT02415192

    Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

    LG Life Sciences 2001 participants Est. completion 2016-11 1 site
    Other conditions: Lower Leg Edema, Orthostatic Hypertension
    View official trial listing →
  • Completed NCT NCT02433119

    The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy

    Not yet reported Dong-A ST Co., Ltd. 238 participants Est. completion 2016-09-08 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT02468232

    Study of Efficacy and Safety of LCZ696 in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction

    Not yet reported Novartis Pharmaceuticals 225 participants Est. completion 2021-02-18 49 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT02470403

    Effect of LIK066 on Body Weight in Patients With Elevated Body Mass Index

    Not yet reported Novartis Pharmaceuticals 181 participants Est. completion 2016-04-04 1 site
    Other conditions: Elevated Body Mass Index
    View official trial listing →
  • Completed NCT NCT02480764

    Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension

    Not yet reported Takeda 612 participants Est. completion 2017-10-13 30 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT02495324

    Fimasartan Achieving SBP Target (FAST) Study

    Not yet reported Boryung Pharmaceutical Co., Ltd 369 participants Est. completion 2017-05 8 sites
    Other conditions: Essential,Hypertension
    View official trial listing →
  • Completed NCT NCT02518451

    Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg

    Not yet reported Dexa Medica Group 48 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02519010

    A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)

    Not yet reported Genuine Research Center, Egypt 36 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02554890

    Comparison of Sacubitril/Valsartan Versus Enalapril on Effect on NT-proBNP in Patients Stabilized From an Acute Heart Failure Episode.

    Not yet reported Novartis Pharmaceuticals 887 participants Est. completion 2018-07-24 123 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02572960

    Physiologic Interactions Between the Adrenal- and the Parathyroid Glands

    Not yet reported University of Aarhus 81 participants Est. completion 2017-05 1 site
    Cardiovascular disease Other conditions: Osteoporosis, Vitamin D Deficiency
    View official trial listing →
  • Terminated NCT NCT02606279

    Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients

    Not yet reported Wake Forest University Health Sciences 1 participants Est. completion 2016-08-04 1 site Stand-alone
    Other conditions: HIV, Aging, Sarcopenia, Angiotensin Receptor Antagonists
    View official trial listing →
  • Completed NCT NCT02639637

    Effect of DPP4 Inhibition on Vasoconstriction

    Not yet reported Vanderbilt University 18 participants Est. completion 2017-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02661217

    Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

    Not yet reported Novartis Pharmaceuticals 1002 participants Est. completion 2018-06-20 152 sites
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT02662894

    Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.

    Not yet reported EMS Est. completion 2020-12 Stand-alone
    Other conditions: Hypertension, Dyslipidemia
    View official trial listing →
  • Completed NCT NCT02678312

    Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCZ696 Followed by a 52-week, Double-blind Study of LCZ696 Compared With Enalapril in Pediatric Patients With Heart Failure

    Not yet reported, Not yet reported Novartis Pharmaceuticals 393 participants Est. completion 2022-01-03 98 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT02690974

    Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting

    Not yet reported Novartis Pharmaceuticals 302 participants Est. completion 2017-11-29 32 sites
    Other conditions: Hearth Failure With Reduced Ejection Fraction (HFrEF)
    View official trial listing →
  • Completed NCT NCT02754518

    Demonstration of Reverse Remodeling Effects of Entresto. Using Echocardiography Endocardial Surface Analysis

    Not yet reported University of Chicago 40 participants Est. completion 2019-04 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT02765594

    Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA Nephropathy

    Not yet reported Peking Union Medical College Hospital 98 participants Est. completion 2019-06 1 site Stand-alone
    Other conditions: Primary IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT02768298

    Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.

    Not yet reported Novartis Pharmaceuticals 201 participants Est. completion 2019-11-25 34 sites
    Heart failure
    View official trial listing →
  • Terminated NCT NCT02787798

    Evaluation of the Entresto Effect on Sympathic Nervous System in Patient With Heart Failure

    Not yet reported University Hospital, Toulouse 4 participants Est. completion 2018-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Terminated NCT NCT02788656

    Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)

    Not yet reported Brigham and Women's Hospital 4 participants Est. completion 2018-11-09 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02815657

    The Drug-drug Interaction of SP2086 and Valsartan

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 16 participants Est. completion 2014-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02817217

    The DDI Study of SP2086 and Valsartan

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 24 participants 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02874794

    Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

    Not yet reported Novartis Pharmaceuticals 465 participants Est. completion 2019-01-26 81 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02884206

    Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

    Not yet reported Novartis Pharmaceuticals 592 participants Est. completion 2022-05-16 135 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02887183

    Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes.

    Not yet reported Novartis Pharmaceuticals 794 participants Est. completion 2018-10-22 77 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT02900378

    randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure

    Not yet reported Novartis Pharmaceuticals 621 participants Est. completion 2018-04-11 119 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02916160

    Sacubitril-valsartan and Heart Failure Patients : the ENTRESTO-SAS Study

    Not yet reported University Hospital, Montpellier 124 participants Est. completion 2020-02-27 6 sites Stand-alone
    Heart failure Other conditions: Sleep Apnea Syndrome
    View official trial listing →
  • Completed NCT NCT02924727

    Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI

    Not yet reported Novartis Pharmaceuticals 5669 participants Est. completion 2021-02-26 486 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02966717

    Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)

    Not yet reported Zhujiang Hospital 116 participants Est. completion 2021-10 1 site
    Other conditions: Renal Insufficiency, Chronic, Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT02973035

    Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With Hypertension

    Not yet reported Asan Medical Center 104 participants Est. completion 2020-01-06 4 sites Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Withdrawn NCT NCT03005184

    Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

    Not yet reported Vanderbilt University Medical Center Est. completion 2020-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT03009474

    Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male Volunteers

    Not yet reported HK inno.N Corporation 52 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT03012763

    Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration Mediums

    Not yet reported University Medicine Greifswald 9 participants
    Other conditions: Pharmacokinetics, Magnetic Resonance Imaging, Administration, Oral
    View official trial listing →
  • Completed NCT NCT03066804

    A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients

    Not yet reported Novartis Pharmaceuticals 2572 participants Est. completion 2019-10-28 380 sites Stand-alone
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT03119623

    Comparing ARNI With ACE Inhibitor on Endothelial Function

    Not yet reported Brigham and Women's Hospital Est. completion 2019-08
    Heart failure
    View official trial listing →
  • Completed NCT NCT03180593

    Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH

    Not yet reported Trinity Hypertension & Metabolic Research Institute 30 participants Est. completion 2018-01-25 1 site
    Other conditions: Hypertension Complicated, Hypertrophy, Left Ventricular, Blood Pressure
    View official trial listing →
  • Completed NCT NCT03190304

    The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure

    Not yet reported University of Sao Paulo General Hospital 52 participants Est. completion 2020-09-23 1 site
    Heart failure Other conditions: Exercise Tolerance, Vasodilation, Body Composition, Muscle Strength
    View official trial listing →
  • Withdrawn NCT NCT03279861

    Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD

    Not yet reported University of Maryland, Baltimore Est. completion 2019-11
    Heart failure Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03300427

    The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients

    Not yet reported Novartis Pharmaceuticals 55 participants Est. completion 2022-03-23 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT03315832

    Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study

    Not yet reported, Not yet reported University Hospital, Limoges Est. completion 2025-07-02 1 site Stand-alone
    Other conditions: Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists, Transcatheter Aortic Valve Replacement, Heart Valve Prosthesis Implantation, Hypertrophy, Left Ventricular
    View official trial listing →
  • Status unknown NCT NCT03359967

    Changes in Intrathoracic Impedance During Sacubitril/Valsartan Treatment

    Central Hospital, Izmir 24 participants Est. completion 2018-08-31
    Heart failure
    View official trial listing →
  • Completed NCT NCT03371797

    Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial

    PharmEvo Pvt Ltd 800 participants Est. completion 2018-11-05 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT03387163

    Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto (Sacubitril/Valsartan) in Heart Failure

    Novartis Pharmaceuticals 402 participants Est. completion 2019-06-21 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT03393377

    Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination

    Not yet reported University Medical Centre Ljubljana 20 participants Est. completion 2017-06 Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Withdrawn NCT NCT03415906

    Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure

    Not yet reported Hannover Medical School Est. completion 2018-09-06 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03432468

    Effect of Fully Blocking Type 1 Angiotensin Receptor on Target Organ Damage of Postmenopausal Hypertensive Women

    Not yet reported LanZhou University 102 participants Est. completion 2019-08-01
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03476616

    Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients

    Not yet reported Hippocration General Hospital 198 participants Est. completion 2025-06-30 1 site
    Other conditions: Hypertension, Obesity
    View official trial listing →
  • Status unknown NCT NCT03502031

    Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

    Not yet reported James A. Tumlin, MD 72 participants Est. completion 2024-10-01 2 sites
    Chronic kidney disease Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT03506412

    Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fraction

    Not yet reported Mayo Clinic 40 participants Est. completion 2021-03-23 1 site
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT03508739

    Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

    Not yet reported University of Pennsylvania Est. completion 2026-06-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Pre-diabetic, Hypertension, Elevated Blood Pressure
    View official trial listing →
  • Completed NCT NCT03532854

    Evaluating a Pharmacokinetic Drug Interaction Between LGEV1801 and LGEV1802

    Not yet reported LG Chem 42 participants Est. completion 2019-01-30 1 site Stand-alone
    Other conditions: Healthy Male Volunteers
    View official trial listing →
  • Completed NCT NCT03536598

    Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

    Not yet reported HK inno.N Corporation 203 participants Est. completion 2017-09-04 Stand-alone
    Other conditions: Hypertension With Hyperlipidemia
    View official trial listing →
  • Status unknown NCT NCT03541109

    A Polypill for Secondary Prevention of Ischemic Heart Disease

    Not yet reported Isfahan University of Medical Sciences 1200 participants Est. completion 2024-08 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03552575

    The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI

    Not yet reported NHS Greater Glasgow and Clyde 93 participants Est. completion 2020-07-25 2 sites Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03553303

    Pharmacodynamic Effects of Sacubitril/Valsartan on Natriuretic Peptides, Angiotensin and Neprilysin

    Not yet reported Oslo University Hospital 40 participants Est. completion 2022-05 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT03553810

    Role of ARNi in Ventricular Remodeling in Hypertensive LVH

    Not yet reported National Heart Centre Singapore 80 participants Est. completion 2024-06-28 1 site Stand-alone
    Other conditions: Hypertensive Heart Disease
    View official trial listing →
  • Status unknown NCT NCT03639480

    Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia

    Not yet reported HK inno.N Corporation 180 participants Est. completion 2018-10 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Completed NCT NCT03639493

    Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

    Not yet reported HK inno.N Corporation 52 participants Est. completion 2018-05-17 1 site Stand-alone
    Other conditions: Healthy Male Subjects
    View official trial listing →
  • Completed NCT NCT03647657

    177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

    Not yet reported University Hospital, Basel, Switzerland 8 participants Est. completion 2021-12-14 1 site
    Other conditions: Thyroid Cancer, Medullary
    View official trial listing →
  • Completed NCT NCT03648333

    Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)

    Not yet reported Hanlim Pharm. Co., Ltd. 27 participants Est. completion 2014-06 Stand-alone
    Other conditions: Healthy Male Subjects
    View official trial listing →
  • Completed NCT NCT03657472

    Bioequivalence Study of CJ-30061 in Healthy Male Volunteers

    Not yet reported HK inno.N Corporation 42 participants Est. completion 2016-11-09 1 site Stand-alone
    Other conditions: Hypertension, Hyperlipidemia
    View official trial listing →
  • Withdrawn NCT NCT03686657

    Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients

    Not yet reported, Not yet reported ARKAY Therapeutics Est. completion 2031-01-31 1 site Stand-alone
    Type 2 diabetes Other conditions: High Blood Pressure, Arthritis, Obesity
    View official trial listing →
  • Completed NCT NCT03717688

    The Effects of Neprilysin on Glucagon-like Peptide-1

    Not yet reported Nicolai Jacob Wewer Albrechtsen 19 participants Est. completion 2019-05-14 1 site
    Heart failure Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT03738878

    Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

    Not yet reported Vanderbilt University Medical Center 4 participants Est. completion 2024-12-01 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT03744975

    PDD in Type 2 Diabetes w/wo Diastolic Dysfunction

    Not yet reported Mayo Clinic 72 participants Est. completion 2025-08-27 1 site
    Type 2 diabetes Other conditions: Diastolic Dysfunction
    View official trial listing →
  • Completed NCT NCT03760588

    Prevention of Cardiac Dysfunction During Breast Cancer Therapy

    Not yet reported Torbjorn Omland 138 participants Est. completion 2024-09-05 4 sites Stand-alone
    Heart failure Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT03771729

    Observation on the Effect of Sacubitril/Valsartan in Advanced Chronic Kidney Disease（CKD）Patients With Heart Failure

    Not yet reported The Second Affiliated Hospital of Harbin Medical University 30 participants Est. completion 2019-06-15
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT03785405

    Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

    Not yet reported Novartis Pharmaceuticals 216 participants Est. completion 2023-12-29 79 sites Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03791723

    Effect of ARNI in Patients With Persistent AF and Enlarged Left Atrium After Catheter Ablation

    Not yet reported The Second Affiliated Hospital of Chongqing Medical University 90 participants Est. completion 2021-12-30 Stand-alone
    Other conditions: Atrial Fibrillation, Cardiac Remodeling, Atrial, Sacubitril/Valsartan
    View official trial listing →
  • Completed NCT NCT03816306

    Six Months Clinical and Echocardiographic Outcome of ARNI LCZ696 Therapy in HFrEF Patients

    Mohammed Alnims 100 participants Est. completion 2019-12-01 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT03821701

    Effect of Angiotensin-Neprilysin Inhibition (ARNI) on Prognosis of Chronic Heart Failure

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 340 participants Est. completion 2022-01-31 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT03830814

    The Effects of Sacubitril/Valsartan on the Heart Functions

    The Young Investigator Group of Cardiovascular Research 100 participants Est. completion 2018-07-31
    Other conditions: Drug Effect
    View official trial listing →
  • Completed NCT NCT03832660

    Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy

    Not yet reported Newcastle University 168 participants Est. completion 2022-06-30 5 sites
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT03872778

    [177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-neoB Lesion Uptake

    Not yet reported, Not yet reported Advanced Accelerator Applications 35 participants Est. completion 2025-11-27 11 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT03893435

    The Role of Sacubitril/Valsartan in Post-acute Myocardial Infarction

    Not yet reported The Young Investigator Group of Cardiovascular Research 192 participants Est. completion 2022-10-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03893526

    Effect of Neprilysin on Glucagon-Like Peptide-1 in Patients With Type 2 Diabetes

    Not yet reported University of Copenhagen 12 participants Est. completion 2021-03-01 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT03909295

    An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.

    Not yet reported Novartis Pharmaceuticals 52 participants Est. completion 2019-11-19 17 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT03917459

    COmparing arNi and Ace For Improving Erectile Dysfunction in mEN With reduCed Ejection Fraction Heart Failure

    Not yet reported Novartis Pharmaceuticals 27 participants Est. completion 2021-05-25 13 sites Stand-alone
    Heart failure Other conditions: Erectile Dysfunction
    View official trial listing →
  • Completed NCT NCT03928158

    LCZ696 in Advanced LV Hypertrophy and HFpEF

    Not yet reported National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 61 participants Est. completion 2023-12-31 1 site
    Heart failure Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT03935087

    Improvement of Left Ventricular Ejection Fraction in ICD Patients Undergoing Therapy With Sacubitril/Valsartan

    Azienda Ospedaliera Cardinale G. Panico 150 participants Est. completion 2019-06-30 6 sites
    Heart failure
    View official trial listing →
  • Active, not recruiting NCT NCT03938389

    The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans

    Not yet reported Ohio State University 90 participants Est. completion 2026-06 1 site Stand-alone
    Prediabetes Other conditions: Obesity, Blood Pressure
    View official trial listing →
  • Completed NCT NCT03988634

    Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)

    Not yet reported Novartis Pharmaceuticals 467 participants Est. completion 2022-12-14 97 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT03990480

    Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level

    Not yet reported Damanhour University 230 participants Est. completion 2019-04-10 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT04023227

    Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

    Not yet reported Novartis Pharmaceuticals 922 participants Est. completion 2025-03-31 79 sites Stand-alone
    Heart failure Other conditions: Chagas Disease
    View official trial listing →
  • Completed NCT NCT04047940

    A Study of LY900020 in Healthy Chinese Participants

    Not yet reported Eli Lilly and Company 32 participants Est. completion 2020-02-18 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04061824

    Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia

    Not yet reported Yonsei University 150 participants Est. completion 2018-12-20 1 site
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04085627

    A Bioequivalence Study of Valsartan / Amlodipine From Valsartan and Amlodipine Tablets (Hua Yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland)

    Not yet reported Second Affiliated Hospital of Wenzhou Medical University 84 participants Est. completion 2019-12-26 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT04092309

    Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

    Not yet reported University of Athens 90 participants Est. completion 2021-09-01 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation, Cardiotoxicity
    View official trial listing →
  • Status unknown NCT NCT04103554

    Sacubitril/Valsartan in Left Ventricular Assist Device Recipients

    Not yet reported University of Zagreb 60 participants Est. completion 2025-02 6 sites Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04107220

    Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure

    Not yet reported Unity Health Toronto 300 participants Est. completion 2020-06 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT04113109

    Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2

    Not yet reported Vanderbilt University Medical Center 46 participants Est. completion 2025-07-30 1 site
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT04128891

    Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction

    Not yet reported Flinders University Est. completion 2024-02-01 Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04133428

    Prospective Observational Study of the Sacubitril-Valsartan Treatment Effectiveness.

    Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 100 participants Est. completion 2021-07-15 1 site
    Heart failure
    View official trial listing →
  • Terminated NCT NCT04149990

    Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

    Not yet reported Jacob Moller 51 participants Est. completion 2023-06-06 2 sites
    Cardiovascular disease Other conditions: Diastolic Dysfunction
    View official trial listing →
  • Completed NCT NCT04153136

    The ENCHANTMENT HIV Study

    Not yet reported Massachusetts General Hospital 39 participants Est. completion 2025-07-09 1 site Stand-alone
    Heart failure Other conditions: HIV/AIDS
    View official trial listing →
  • Completed NCT NCT04164732

    Study of Efficacy of Oral Sacubitril/Valsartan in Adult Patients With Non-obstructive Hypertrophic Cardiomyopathy

    Not yet reported Novartis Pharmaceuticals 46 participants Est. completion 2023-08-22 18 sites
    Other conditions: Cardiomyopathy, Hypertrophic
    View official trial listing →
  • Status unknown NCT NCT04174456

    Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy

    Not yet reported Dong-A University 40 participants Est. completion 2021-12-31 1 site
    Other conditions: Dilated Cardiomyopathy
    View official trial listing →
  • Status unknown NCT NCT04185090

    To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults

    Not yet reported IlDong Pharmaceutical Co Ltd 30 participants Est. completion 2020-04 Stand-alone
    Other conditions: Hypertension, Dyslipidemias
    View official trial listing →
  • Status unknown NCT NCT04185103

    Changes in the T-wave Alternans in Patients With Heart Failure Treated Wih Sacubitril-Valsartan

    Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 20 participants Est. completion 2020-12-15 4 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04197050

    Effect of Sacubitril/Valsartan on Reduced Right Ventricular Ejection Fraction in Patients With CTD

    Not yet reported RenJi Hospital 60 participants Est. completion 2022-11 1 site Stand-alone
    Other conditions: Myocardial Injury, Connective Tissue Diseases
    View official trial listing →
  • Withdrawn NCT NCT04206865

    Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output

    Not yet reported The Cleveland Clinic Est. completion 2020-09-10 1 site Stand-alone
    Other conditions: Cardiogenic Shock
    View official trial listing →
  • Status unknown NCT NCT04217135

    The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation

    Not yet reported Kaohsiung Veterans General Hospital. 400 participants Est. completion 2022-07-31 1 site
    Heart failure Other conditions: Mitral Regurgitation
    View official trial listing →
  • Completed NCT NCT04218435

    Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients

    Clinision 200 participants Est. completion 2020-12-30 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04263922

    Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3

    Not yet reported The First Affiliated Hospital of Dalian Medical University 466 participants Est. completion 2026-03-30 34 sites Stand-alone
    Other conditions: Renal Insufficiency, Chronic
    View official trial listing →
  • Status unknown NCT NCT04270344

    The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment

    JW Pharmaceutical 905 participants Est. completion 2022-06-30 1 site
    Other conditions: Hypercholesterolemia
    View official trial listing →
  • Completed NCT NCT04332315

    Vaginally Assisted Laparoscopic Sacropolpopexy

    Not yet reported Bezmialem Vakif University 87 participants Est. completion 2020-03-30
    Other conditions: Pelvic Organ Prolapse
    View official trial listing →
  • Terminated NCT NCT04335786

    Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

    Not yet reported Radboud University Medical Center 23 participants Est. completion 2021-05-25 7 sites Stand-alone
    Other conditions: Acute Respiratory Distress Syndrome, SARS-CoV-2, COVID, COVID-19, Severe Acute Respiratory Syndrome
    View official trial listing →
  • Status unknown NCT NCT04342351

    Early Treatment of ARNI on Myocardial Remodeling and Progress

    Not yet reported RenJi Hospital 280 participants Est. completion 2021-12-30 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04394117

    Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

    Not yet reported The George Institute 787 participants Est. completion 2022-01-17 22 sites
    Other conditions: Coronavirus Disease 2019, COVID-19
    View official trial listing →
  • Completed NCT NCT04397302

    Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction

    Italian Society of Cardiology 652 participants Est. completion 2020-03-16 1 site
    Heart failure Other conditions: Left Ventricular Dysfunction, Ventricular Remodeling
    View official trial listing →
  • Status unknown NCT NCT04398771

    To Evaluate Safety and Effectiveness of RovatitanTab.

    LG Chem 1000 participants Est. completion 2022-05-31
    Other conditions: Hypertension, Hyperlipidemias
    View official trial listing →
  • Completed NCT NCT04434170

    Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart Failure

    Centro Cardiologico Monzino 112 participants Est. completion 2021-12-15 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT04467931

    ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

    University of Utah 22213 participants Est. completion 2020-12-31 1 site
    Other conditions: Hypertension, COVID
    View official trial listing →
  • Terminated NCT NCT04491136

    Effective Study of ARNI on Ventricular Arrhythmia in HFrEF Patients With ICD or CRT-D (RHYTHM)

    Not yet reported Novartis Pharmaceuticals 201 participants Est. completion 2023-06-08 23 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT04498780

    Hemodynamic Effects of ARNI on Noninvasive Pressure-volume Analysis in Patients With Chronic Heart Failure

    University of Leipzig 117 participants Est. completion 2026-04-08 2 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04572724

    The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value

    Not yet reported Shenzhen Second People's Hospital 120 participants Est. completion 2023-06 1 site Stand-alone
    Heart failure Other conditions: Peritoneal Dialysis Complication, Hemodialysis Complication
    View official trial listing →
  • Completed NCT NCT04575675

    Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy

    Not yet reported Cheng-Hsin General Hospital 78 participants Est. completion 2020-12-30 1 site Stand-alone
    Heart failure Other conditions: Hypotension
    View official trial listing →
  • Completed NCT NCT04587947

    Influence of Sacubitril/Valsartan on Autonomic Cardiac Nervous System in Heart Failure Patients: an Exploratory Study

    Not yet reported St. Josefs-Hospital Wiesbaden GmbH 63 participants Est. completion 2022-05-31 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT04591210

    The COVID-RASi Trial (COVID-19)

    Not yet reported Ottawa Heart Institute Research Corporation 372 participants Est. completion 2024-12-30 31 sites Stand-alone
    Cardiovascular disease Other conditions: COVID-19
    View official trial listing →
  • Terminated NCT NCT04606563

    Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

    Not yet reported University of British Columbia 341 participants Est. completion 2022-04-22 13 sites Stand-alone
    Other conditions: Covid19, SARS-CoV Infection
    View official trial listing →
  • Status unknown NCT NCT04623866

    Study on the Treatment of Children With Purpura Nephritis With Huaiqihuang Granules

    Not yet reported The Children's Hospital of Zhejiang University School of Medicine 10 participants Est. completion 2021-08-30 2 sites
    Other conditions: Henoch Schönlein Purpura Nephritis
    View official trial listing →
  • Completed NCT NCT04637152

    Sacubitril/Valsartan in Resistant Hypertension

    Not yet reported Hospital Geral Roberto Santos 80 participants Est. completion 2022-08-17 2 sites Stand-alone
    Other conditions: Resistant Hypertension, Blood Pressure
    View official trial listing →
  • Withdrawn NCT NCT04637555

    Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)

    Not yet reported Novartis Pharmaceuticals Est. completion 2023-06-01 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04649229

    Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3

    Not yet reported Yale University 46 participants Est. completion 2025-05-22 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04686643

    Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

    Not yet reported Ahn-Gook Pharmaceuticals Co.,Ltd 306 participants Est. completion 2022-05-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT04687111

    Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation

    Not yet reported Mark Ledwidge 250 participants Est. completion 2021-06-11 2 sites Stand-alone
    Other conditions: Atrial Remodeling, Myocardial Dysfunction, Left Ventricular Remodeling, Left Ventricular Diastolic Dysfunction, Hypertension, Cardiovascular Morbidity, Fibrosis Myocardial, Inflammatory Myopathy, Atrial Arrhythmia
    View official trial listing →
  • Completed NCT NCT04688294

    The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure

    Not yet reported Amir Safwat 60 participants Est. completion 2021-07-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04707261

    Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS)

    Not yet reported Xiangtan Central Hospital 1990 participants Est. completion 2026-01-01 1 site Stand-alone
    Heart failure Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT04707508

    Effect of Adding Renin-Angiotensin System Inhibitors to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Ellitus

    Not yet reported Nantou Christian Hospital 203 participants Est. completion 2019-11-29 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04736433

    Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.

    Brigham and Women's Hospital 6066 participants Est. completion 2021-02-18 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04743063

    Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

    Brigham and Women's Hospital 40000 participants Est. completion 2022-12-31 1 site
    Heart failure Other conditions: Frailty
    View official trial listing →
  • Completed NCT NCT04753112

    Treatment of PH With Angiotensin II Receptor Blocker and Neprilysin Inhibitor in HFpEF Patients With CardioMEMS Device

    Not yet reported Germans Trias i Pujol Hospital 14 participants Est. completion 2021-09-20 1 site Stand-alone
    Other conditions: Pulmonary Hypertension
    View official trial listing →
  • Status unknown NCT NCT04769778

    Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine

    Not yet reported Josep M Cruzado 180 participants Est. completion 2023-06 1 site Stand-alone
    Other conditions: Chronic Kidney Allograft Nephropathy
    View official trial listing →
  • Completed NCT NCT04781881

    Special Drug Use Surveillance for Entresto Tablets

    Novartis Pharmaceuticals 688 participants Est. completion 2023-04-21 121 sites
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04800081

    Effect of LCZ696 on Urinary Microalbumin and Pulse Wave Velocity in Perimenopausal Patients With Hypertension

    Not yet reported LanZhou University 264 participants Est. completion 2021-07-09 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT04803175

    Sacubitril/Valsartan Versus Valsartan in Heart Failure With Improved Ejection Fraction

    Samsung Medical Center 100 participants Est. completion 2025-02 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT04853758

    Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy With Reduced Ejection Fraction: ANSWER-HF.

    Not yet reported University of Sao Paulo General Hospital 200 participants Est. completion 2024-12-01 1 site
    Other conditions: Chagas Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT04859452

    A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 56 participants Est. completion 2021-07-09 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Withdrawn NCT NCT04872959

    TRANSFORM Heart Failure with Reduced Ejection Fraction

    Not yet reported Massachusetts General Hospital Est. completion 2024-05
    Heart failure
    View official trial listing →
  • Completed NCT NCT04883528

    Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019

    Not yet reported, Not yet reported Duke University 42 participants Est. completion 2023-06-13 1 site Stand-alone
    Other conditions: Covid19
    View official trial listing →
  • Status unknown NCT NCT04929600

    Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.

    Not yet reported Shanghai Jiao Tong University School of Medicine 120 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Hypertension, Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT05021419

    Efficacy of a Streamlined Heart Failure Optimization Protocol

    Not yet reported The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust 60 participants Est. completion 2024-01-07 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT05053893

    Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome

    Not yet reported The Affiliated Hospital of Qingdao University 40 participants Est. completion 2022-09-01 1 site Stand-alone
    Other conditions: Cardio-Renal Syndrome
    View official trial listing →
  • Terminated NCT NCT05056727

    A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

    Not yet reported AstraZeneca 1112 participants Est. completion 2024-02-07 276 sites Stand-alone
    Other conditions: Renal Insufficiency, Chronic, Hyperkalemia
    View official trial listing →
  • Status unknown NCT NCT05060588

    Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction

    Not yet reported Qingdao Central Hospital 200 participants Est. completion 2023-02 1 site Stand-alone
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT05077462

    A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

    Not yet reported AJU Pharm Co., Ltd. 60 participants Est. completion 2022-04-30 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT05077475

    A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52L in Healthy Volunteers

    Not yet reported AJU Pharm Co., Ltd. 60 participants Est. completion 2022-04-30 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT05089539

    The Effect of Angiotensin Receptor-Neprilysin Inhibition on Cardiac Fibrosis in Patients With HFpEF

    Not yet reported Chongqing Medical University 60 participants Est. completion 2022-04-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05095922

    Effect of HMP on Diabetic Microangiopaemia in T2DM

    Not yet reported Affiliated Hospital of Nantong University 40 participants Est. completion 2024-05-30 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetic Angiopathies
    View official trial listing →
  • Completed NCT NCT05096143

    A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

    Novartis Pharmaceuticals 42269 participants Est. completion 2020-10-19 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT05164653

    Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)

    Not yet reported Saga University 400 participants Est. completion 2025-03 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05168787

    Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction

    Methodist Health System 6558 participants Est. completion 2025-07-08 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT05212597

    Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB

    Not yet reported Samsung Medical Center 100 participants Est. completion 2024-12 1 site
    Other conditions: Aortic Valve Insufficiency
    View official trial listing →
  • Status unknown NCT NCT05259020

    To Evaluate the Pharmacokinetics and the Safety of ID14009 Compared to Coadministration of ID1805 With ID1803 in Healthy Adult Volunteers

    Not yet reported IlDong Pharmaceutical Co Ltd 60 participants Est. completion 2022-03-30 1 site Stand-alone
    Other conditions: Dyslipidemias, Hypertension
    View official trial listing →
  • Status unknown NCT NCT05269615

    Exercise-induced Erythropoiesis: the Mechanistic of Angiotensin II

    Not yet reported The University of Hong Kong 80 participants Est. completion 2024-09-30 1 site
    Other conditions: Exercise Physiology
    View official trial listing →
  • Enrolling by invitation NCT NCT05279742

    Enhancing the Natriuretic Peptide System in HFpEF

    Not yet reported, Not yet reported Horng Chen 60 participants Est. completion 2027-04 1 site Stand-alone
    Heart failureChronic kidney disease
    View official trial listing →
  • Completed NCT NCT05353166

    REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge Pressure

    Not yet reported Regeneron Pharmaceuticals 59 participants Est. completion 2025-06-02 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05359068

    Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

    Not yet reported Shanghai Pharmaceuticals Holding Co., Ltd 957 participants Est. completion 2023-12-26 40 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT05361824

    Ketorolac-an Option for Post Operative Pain Management After Elective Cardiac Surgery.

    Not yet reported National Institute of Cardiovascular Diseases, Pakistan 60 participants Est. completion 2021-07-06 1 site
    Cardiovascular disease Other conditions: Post Operative Pain, Analgesia, Coronary Artery Bypass Grafting Surgery
    View official trial listing →
  • Completed NCT NCT05366101

    Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy

    Not yet reported, Not yet reported Newcastle-upon-Tyne Hospitals NHS Trust 168 participants Est. completion 2022-03-31 1 site
    Other conditions: Hypertrophic Cardiomyopathy
    View official trial listing →
  • Completed NCT NCT05387967

    Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction

    Not yet reported National Institute of Cardiovascular Diseases, Pakistan 121 participants Est. completion 2021-09-30 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05448872

    Real World Experience in Heart Failure With Reduced Ejection Fraction (HFrEF) Patients Treated With sAc/vaL.

    Novartis Pharmaceuticals 924 participants Est. completion 2021-09-15 1 site
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT05487261

    Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction

    Not yet reported Clinical Hospital Heliodor Swiecicki of the Medical University of Karol Marcinkowski in Poznań 260 participants Est. completion 2025-11 5 sites Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05498181

    Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation

    Not yet reported Brigham and Women's Hospital 45 participants Est. completion 2026-01-31 1 site Stand-alone
    Other conditions: Hemodialysis
    View official trial listing →
  • Status unknown NCT NCT05545059

    Effects and Safety of Sacubitril/Valsartan on Refractory Hypertension

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 138 participants Est. completion 2023-03-31 1 site Stand-alone
    Other conditions: Resistant Hypertension
    View official trial listing →
  • Status unknown NCT NCT05580510

    " Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "

    Not yet reported, Not yet reported Instituto Nacional de Cardiologia Ignacio Chavez 160 participants Est. completion 2024-03-29 1 site Stand-alone
    Heart failure Other conditions: Congenital Heart Disease
    View official trial listing →
  • Completed NCT NCT05593575

    Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

    Not yet reported Shanghai Pharmaceuticals Holding Co., Ltd 305 participants Est. completion 2024-12-31 45 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT05609513

    Integration of Hypertension Management in HIV Care in Uganda

    Not yet reported Infectious Diseases Research Collaboration, Uganda 87421 participants Est. completion 2025-10-03 16 sites Stand-alone
    Other conditions: HIV/AIDS, Hypertension
    View official trial listing →
  • Completed NCT NCT05636774

    Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines Trial

    Not yet reported University Hospital, Essen 97 participants Est. completion 2025-03-01 1 site Stand-alone
    Other conditions: Patients With Advanced Cancer Receiving Specialized Palliative Care
    View official trial listing →
  • Active, not recruiting NCT NCT05637853

    Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction

    Not yet reported Göteborg University 60 participants Est. completion 2026-08-26 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT05638880

    Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney Disease

    Not yet reported Mostafa Bahaa 60 participants Est. completion 2025-12-20 1 site Stand-alone
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Completed NCT NCT05681273

    Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.

    Not yet reported Chipscreen Biosciences, Ltd. 48 participants Est. completion 2023-03-21 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05848206

    Impact of Formulary Coverage of Entresto (Sacubitril/Valsartan) on Prescription Abandonment/Rejection and Subsequent Treatment and Economic Outcomes in Chronic Heart Failure Patients in the U.S.

    Novartis Pharmaceuticals 251831 participants Est. completion 2022-04-29 1 site
    Heart failure
    View official trial listing →
  • Withdrawn NCT NCT05870709

    Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients With Chronic Heart Failure

    Novartis Pharmaceuticals Est. completion 2024-10-31
    Heart failure
    View official trial listing →
  • Completed NCT NCT05874349

    Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease

    Hospital Mutua de Terrassa 200 participants Est. completion 2023-01-01 1 site
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT05881720

    Sacubitril/Valsartan Versus Valsartan in Heart Failure

    Not yet reported Damanhour University 80 participants Est. completion 2023-06-19 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT05892146

    Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

    Not yet reported National Cheng-Kung University Hospital 100 participants Est. completion 2025-12-31 1 site Stand-alone
    Heart failure Other conditions: Chemotherapeutic Toxicity, Cardiotoxicity, Breast Cancer, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT05899920

    Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy

    Not yet reported Ryazan State Medical University 190 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Resistant Arterial Hypertension
    View official trial listing →
  • Completed NCT NCT05920005

    Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension

    Not yet reported Hospital Israelita Albert Einstein 702 participants Est. completion 2025-05-01 22 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05963282

    Comparative Effectiveness of Entresto (Sacubitril/Valsartan) Versus ACEi/ARB in de Novo Heart Failure Patients

    Novartis Pharmaceuticals 9870 participants Est. completion 2022-07-19 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT05976230

    Special Drug Use Surveillance of Entresto Tablets (Hypertension)

    Novartis Pharmaceuticals 1125 participants Est. completion 2025-05-29 117 sites
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT05989503

    Initiation of ARNi and SGLT2i in Patients With HFrEF

    Not yet reported Universidade do Porto 62 participants Est. completion 2025-07-31 5 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT05991284

    Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Valve Regurgitation

    Not yet reported Ziekenhuis Oost-Limburg 84 participants Est. completion 2026-05-09 1 site
    Heart failure Other conditions: Functional Mitral Regurgitation
    View official trial listing →
  • Completed NCT NCT06029712

    Heart Failure Polypill at a Safety Net Hospital

    Not yet reported University of California, San Francisco 35 participants Est. completion 2025-01-29 1 site Stand-alone
    Heart failure Other conditions: HIV Infections
    View official trial listing →
  • Status unknown NCT NCT06035978

    Determination of Drug Levels for Pharmacotherapy of Heart Failure

    Not yet reported University Hospital Ostrava 100 participants Est. completion 2026-04 1 site Stand-alone
    Cardiovascular diseaseHeart failure
    View official trial listing →
  • Completed NCT NCT06090487

    Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function Performance

    Not yet reported Ain Shams University 30 participants Est. completion 2024-03-01 1 site
    Heart failure
    View official trial listing →
  • Terminated NCT NCT06142383

    A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

    Not yet reported Novartis Pharmaceuticals 136 participants Est. completion 2024-11-01 62 sites
    Heart failure
    View official trial listing →
  • Completed NCT NCT06149104

    A Safety Study of Sacubitril/Valsartan in Japanese Pediatric Patients With Heart Failure Due to Systemic Left Ventricle Systolic Dysfunction Who Have Completed CLCZ696B2319E1 Study

    Not yet reported Novartis Pharmaceuticals 8 participants Est. completion 2024-08-14 6 sites Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT06149806

    National Registry of Adult Heart Failure Patients With Complex Congenital Heart Disease: Systemic Right Ventricle and Single Ventricle Treated With Sacubitril/Valsartan

    University Hospital, Grenoble 50 participants Est. completion 2025-12 1 site
    Other conditions: Complex Congenital Heart Disease
    View official trial listing →
  • Status unknown NCT NCT06193044

    Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets

    Not yet reported International Bio service 48 participants Est. completion 2024-07-12 Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT06193187

    A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories (Thailand) Limited 48 participants Est. completion 2024-08 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT06248112

    Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets

    Not yet reported Bio-innova Co., Ltd 40 participants Est. completion 2024-07-06 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT06266988

    A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

    Not yet reported Viatris Inc. 48 participants Est. completion 2024-08 Stand-alone
    Heart failure
    View official trial listing →
  • Status unknown NCT NCT06273254

    A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions

    Not yet reported Viatris Inc. 48 participants Est. completion 2024-09 1 site Stand-alone
    Other conditions: Bioequivalence Study
    View official trial listing →
  • Status unknown NCT NCT06341101

    Timely Recovery After Subclinical Heart Failure

    Not yet reported Academisch Ziekenhuis Maastricht 130 participants Est. completion 2026-03-01 1 site Stand-alone
    Heart failure Other conditions: Diastolic Dysfunction
    View official trial listing →
  • Status unknown NCT NCT06344247

    Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease

    Not yet reported RenJi Hospital 48 participants Est. completion 2025-12-01 1 site Stand-alone
    Chronic kidney disease Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06357104

    Detoxification From the Lipid Tract

    Not yet reported Pachankis, Yang I., M.D. 1 participants Est. completion 2024-03-20 1 site Stand-alone
    Other conditions: COVID-19 Vaccine Adverse Reaction
    View official trial listing →
  • Completed NCT NCT06395194

    Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension

    Not yet reported Oslo University Hospital 15313 participants Est. completion 2003-12-05
    Other conditions: Essential Hypertension
    View official trial listing →
  • Status unknown NCT NCT06439069

    BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients

    Lithuanian University of Health Sciences 340 participants Est. completion 2024-12-01 1 site
    Heart failure Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT06487949

    Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy

    Not yet reported Shiraz University of Medical Sciences 114 participants Est. completion 2023-12-01 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Status unknown NCT NCT06501651

    Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

    Not yet reported Sichuan Academy of Medical Sciences 297 participants Est. completion 2025-04-10 1 site Stand-alone
    Type 2 diabetes Other conditions: Essential Hypertension, Nephropathy
    View official trial listing →
  • Status unknown NCT NCT06515678

    Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

    Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites
    Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
    View official trial listing →
  • Withdrawn NCT NCT06536309

    Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction

    Not yet reported Brigham and Women's Hospital Est. completion 2026-08-27 Stand-alone
    Heart failure Other conditions: Myocardial Fibrosis
    View official trial listing →
  • Completed NCT NCT06604897

    Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension

    Novartis Pharmaceuticals 1405 participants Est. completion 2025-10-31 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT06697353

    An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan

    Bayer 4936 participants Est. completion 2025-09-19 1 site
    Heart failure
    View official trial listing →
  • Not yet recruiting NCT NCT06712030

    Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection Fraction

    Not yet reported Puerta de Hierro University Hospital 114 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
    View official trial listing →
  • Not yet recruiting NCT NCT06716970

    QR12000 Compound Tablets in Patients with Moderate to Severe Essential Hypertension

    Not yet reported Wuhan Createrna Science and Technology Co., Ltd 810 participants Est. completion 2027-02-28 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT06771245

    A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 606 participants Est. completion 2026-10-30 Stand-alone
    Other conditions: Mild-to-moderate Essential Hypertension
    View official trial listing →
  • Enrolling by invitation NCT NCT06863987

    A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents

    Not yet reported Shandong New Time Pharmaceutical Co., LTD 342 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT06900803

    Evaluating Dashboard-Integrated Pharmacist-Led Education on Improving Sacubitril/Valsartan Adherence in Heart Failure (PharmD ASSIST HFrEF)

    Not yet reported National Taiwan University Hospital 200 participants Est. completion 2027-10-31 Stand-alone
    Heart failure Other conditions: Sacubitril/Valsartan, Medication Adherence
    View official trial listing →
  • Completed NCT NCT06922253

    Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97 mg/103 mg)

    Not yet reported Humanis Saglık Anonim Sirketi 48 participants Est. completion 2025-03-17 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT07023016

    Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure

    Not yet reported, Not yet reported National Heart Institute, Egypt 515 participants Est. completion 2025-02-28 2 sites Stand-alone
    Heart failureChronic kidney disease
    View official trial listing →
  • Completed NCT NCT07088471

    Cardiac Left Atrial Evaluation and Response in HFrEF With Sacubitril/Valsartan

    Connolly Hospital Blanchardstown 334 participants Est. completion 2025-08-01 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT07116863

    A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension

    Not yet reported Kyungdong Pharmaceutical Co., Ltd. 286 participants Est. completion 2024-09-13 2 sites Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT07130175

    Radiofrequency Ablation for Polymorphic Ventricular Tachycardia With Heart Failure (RFCA for PMVT-HF)

    Not yet reported Qian Feng 118 participants Est. completion 2024-12-31 1 site Stand-alone
    Heart failure Other conditions: Polymorphic Ventricular Tachycardia
    View official trial listing →
  • Not yet recruiting NCT NCT07139405

    TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin Therapy

    Not yet reported Myopharm Limited 48 participants Est. completion 2027-12-30 3 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07197372

    Comparative Efficacy of ARNI Versus ACE Inhibitor Therapy in Egyptian Children With Dilated Cardiomyopathy

    Assiut University 70 participants Est. completion 2027-12-30
    Other conditions: ARNI, Pediatric Dilated Cardiomyopathy, ACE Inhibitor
    View official trial listing →
  • Not yet recruiting NCT NCT07232966

    Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension

    Not yet reported Yan Li 220 participants Est. completion 2029-06-30 1 site
    Other conditions: Resistant Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07241338

    Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity

    Not yet reported Jing Liu 104 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07262710

    Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

    First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT07327749

    Comparing Bisoprolol and Valsartan-Amlodipine for Hypertension

    Not yet reported Shiraz University of Medical Sciences 59 participants Est. completion 2025-12-12 1 site
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT07341893

    Sacubitril-valsartan in Patients With Heart Failure.

    Not yet reported Damanhour University 60 participants Est. completion 2026-03-30 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT07376265

    A Real-world Study to Compare the Effectiveness of Sacubitril/Valsartan Versus ACEi/ARB in HFrEF Patients

    Novartis Pharmaceuticals 1249 participants Est. completion 2024-04-11 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT07417215

    The Effect of Sacubitril and Valsartan on Heart Function in Chronic Hemodialysis Patients With HFpEF

    Not yet reported University Clinical Hospital Mostar 52 participants Est. completion 2026-05-10 1 site Stand-alone
    Heart failure Other conditions: Hemodialysis, Sacubitril/Valsartan
    View official trial listing →
  • Not yet recruiting NCT NCT07465666

    A Real-world Study of the Effectiveness of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Hypertensive Patients in the United Arab Emirates

    Novartis Pharmaceuticals 500 participants Est. completion 2027-08-15
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT07465679

    A Real-world Study of Clinical Treatment Guidelines for Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan

    Novartis Pharmaceuticals 2508 participants Est. completion 2026-03-10 1 site
    Heart failure
    View official trial listing →
  • Not yet recruiting NCT NCT07486453

    Bioequivalence Study of Sacubitril Alisartan Amlodipine Tablets

    Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 60 participants Est. completion 2026-04-25 1 site
    Other conditions: Primary Hypertension
    View official trial listing →
  • Completed NCT NCT07527767

    Secondary Use of PARALLEL-HF Data

    Novartis Pharmaceuticals 236 participants Est. completion 2023-12-15 1 site
    Heart failure
    View official trial listing →
  • Completed NCT NCT07544888

    Effectiveness of Valsartan Alone vs Combination Therapy in Hypertensive Heart Disease

    Not yet reported Shaikh Zayed Hospital, Lahore 118 participants Est. completion 2026-03-01 1 site Stand-alone
    Other conditions: Heart Diseases, Hypertension
    View official trial listing →
  • Completed NCT NCT07700875

    A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential Hypertension

    Not yet reported Wuhan Createrna Science and Technology Co., Ltd 391 participants Est. completion 2023-09-11 1 site Stand-alone
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT07702669

    Modified Huanglian Wendan Decoction for Metabolic Syndrome

    Not yet reported First Affiliated Hospital of Heilongjiang Chinese Medicine University 180 participants Est. completion 2025-08-31 1 site Stand-alone
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT07704684

    Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine

    Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 376 participants Est. completion 2025-09-08 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Completed NCT NCT07704697

    Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Sacubitril/Allisartan

    Not yet reported Shenzhen Salubris Pharmaceuticals Co., Ltd. 346 participants Est. completion 2025-11-24 1 site
    Other conditions: Essential Hypertension
    View official trial listing →
  • Not yet recruiting NCT NCT07735130

    Angiotensin Receptor Blocker After TAVR in Severe Aortic Stenosis With Left Ventricular Hypertrophy (ARBITAR)

    Not yet reported Seoul National University Hospital 632 participants Est. completion 2030-06-15 1 site Stand-alone
    Other conditions: Transcatheter Aortic Valve Replacement (TAVR), Left Ventricular Hypertrophy, Severe Aortic Stenosis
    View official trial listing →
  • Completed NCT NCT07746908

    Bioequivalence Study of Valsatril Tablet Versus Entresto® Sacubitril/Valsartan 24/26 mg Tablet.

    Not yet reported Center for Bioequivalence Studies and Clinical Research 60 participants Est. completion 2025-07-18 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT07814482

    Effect of Sacubitril-Valsartan on Estimated Pulmonary Artery Systolic Pressure in Patients With Heart Failure With Reduced Ejection Fraction Heart Failure

    Not yet reported Aswan University 59 participants Est. completion 2026-07-12 1 site
    Other conditions: PASP
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Valsartan, Valsartan and Hydrochlorothiazide, Sacubitril and Valsartan, Valsartan 160mg (blinded), Diovan

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.